AV

Alice Vickers

Biotech Investment Associate at Forbion | PhD Stem Cells & Genetics

Netherlands

Investor
VC

Invests in

Stages:

Series A
Seed

Locations:

United Kingdom

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Cell Biology
Genetics
Research
Teamwork
Communication
Customer Service
Time Management
Social Media
Microsoft Office
Leadership
Data Analysis
Molecular Biology
Microsoft Excel

Education

Work Experience

Forbion

2023

  • Associate

    2024

  • Analyst

    2023 - 2024

    Forbion invests in life sciences companies that are active in the bio-pharmaceutical space. Forbion manages €3 billion across multiple fund strategies that cover all stages of drug development.

INKEF Capital

2021 - 2023

  • Healthcare Investor

    2021 - 2023

    Inkef is a €500M VC fund, backing promising early stage Healthcare and Technology companies in Europe. Board Observer: NMD Pharma, Salvia BioElectronics, Audion Therapeutics

Syncona Limited

2020 - 2020

  • Project Advisor

    2020 - 2020

    Syncona is a leading venture capital fund focused on founding, building and funding global leaders in life science.

M Ventures

2019 - 2019

  • Fellow

    2019 - 2019

    Strategic, corporate venture arm of Merck KGaA.

Innovation Forum

2016 - 2019

  • President (formerly Business Development Director)

    2016 - 2019

    The Innovation Forum is an accelerator for healthcare ventures.

St John's Laboratory Ltd

2015 - 2016

  • Marketing & Business Development Executive

    2015 - 2016

Imperial College London

2015 - 2015

  • Research Scientist

    2015 - 2015

    Prof. Mustafa Djamgoz lab.